To identify the risk factors for infection and to develop a model for the prediction of infection in hospitalized patients with active systemic lupus erythematosus (SLE), we carried out a retrospective cohort study with clinical data collected from 121 consecutive patients with active SLE. Seventeen patients had infection within 6 months of beginning steroid therapy for active SLE. Independent multivariate predictors of infection were a decrease in the serum albumin value, an increase in the serum creatinine value, and prednisolone use in a dose of >60 mg/day without methylprednisolone pulse therapy. The error rate of the model by 10-fold cross-validation method was 12%, sensitivity was 65%, specificity was 91%, and positive predictive value was 55%. Four nonsurvivors were correctly discriminated. Use of this model could contribute to earlier diagnosis of infection and may assist decisions regarding empiric antimicrobial administration in patients withSLE.
Introduction
Infection often complicates systemic lupus erythematosus (SLE) and is a frequent cause of death in patients with SLE (1) . Therefore it is important to identify risk factors for infection in the management of SLE patients. Risk factor modification or prophylactic antibiotic use could decrease the incidence or severity of infection, improving the prognosis for SLEpatients.
And when the frequency of infection becomes a serious problem, for example in a clinical trial of immunosuppressant therapy for SLEor in a comparison of the prognosis of SLE amongseveral hospitals, it is desirable to use infectious risk as a confounding factor in the statistical analysis.
For editorial comment, see p 593.
Some infectious risk factors have been reported to date, including an increasing corticosteroid dose in the presence of decreasing renal function (2) , an increasing corticosteroid dose and active renal disease associated with an abnormal urinary sediment (3), the presence of an "active disease" (4, 5) , the presence of serum inhibitors of complement-derived chemotactic activity (6) , and low levels of serum IgG3 and IgG4 (7) . There have been few reports, however, on the clinical application of predictors of infection. In this report we describe the development of a clinically applicable model for predicting infection in SLE patients, using the clinical findings of patients with active SLEat the time of admission as predictor variables for infection that would develop within six months following the start of therapy. This is because fatal infections often occur when SLE is active (8, 9) and it rarely occurs in outpatients, most of whomhave inactive SLE on maintenance therapy.
Subjects and Methods
Pa tien ts Consecutive patients with active SLEolder than 15 years old, whowere admitted to the University of Tsukuba Hospital between 1982 and 1994 were enrolled in the study. If patients had more than one flare-up of SLEduring that period, only data from the first episode was used. The 1982 revised criteria for the classification of SLE (10) was used to diagnose SLE, and "active" disease at the time of admission was defined by the Lupus Activity Criteria Count (1 1). Patients were identified by a computer listing of all patients with a discharge diagnosis of SLE. Patients were excluded if treatment for SLE with corticosteroid or cytotoxic agents (i.e., start of corticosteroid in fresh cases or increasing corticosteroid dose in recurrence) had been started in other hospitals before admission to our facility, because our purpose was to predict which patients would have infection within six months after the start of therapy for active SLE using clinical findings not modified by the therapy. validation and the bootstrap method (22) , which could provide a nearly unbiased estimate of error rate, sensitivity (Se), and specificity (Sp) of a prediction rule using only the original data, because over fitting becomesa real danger whenthe prediction rule is allowed to become complicated. Briefly, in 10-fold cross-validation patients were split randomly into 10 roughly equal-sized groups. For the Mi group, the model was fitted to the data of the other 9 groups, and the predicted probability of infection for the Ml group was calculated using the fitted model.
The above was donefork= 1, 2,..., 10.
In the bootstrap method (22) , bootstrap samples x*^= (x*bh x*b2,...,x*b\2\), b = 1,..., 400 were generated from a training sample x = (jcj, x2..., X121) by random sampling with replacement. Inthis methodxx = (^1,y1),...,x121 = (^i2i,}7i2i) are regarded as an independent and identically distributed random sample from a population with an unknown probability distri- whenobservations are distributed according to the empirical distribution F. The difference
is the excess error, excess Se, or excess Sp of r\p. The bootstrap method constructs r\p*, which is the realized prediction rule based on x*b, and then forms
The bootstrap estimate of expected excess error, excess Se, or excess Sp is 400 rboot= ,nn J-jRuà" Therefore, for example, the final estimate of prediction error is qapp plus fw
Comparison to the predictive value of the SLEDAI score (20) was achieved using receiver operating characteristic (ROC) curve analysis (23) . The area under an ROCcurve can be interpreted as the probability of correctly identifying patients who will develop infection. This area ranges from 0.5 (no accuracy in predicting infection) to 1.0 (perfect accuracy). For calculating the area under the ROCcurve, weemployeda method described by Hanley and McNeil (24) . Data managementand most statistical analyses were performed using the program package SPSS 6.1 (SPSS Inc, Chicago) on a personal computer.
Results
Characteristics of the study population During the study period, 134 patients were admitted to the University ofTsukuba Hospital because of active SLE. Of these patients, 1 3 were excluded because corticosteroid therapy had been started before admission in 8 and because the following infections were already present at the time of admission in 5: Characteristics of infections in the study population Infection developed in 17 patients within 6 months of beginning corticosteroid therapy for active SLE. The period of time from the start of SLEtherapy to infection was 52±44 days (mean±SD,range: 8-154). Table 2 shows the causative microorganisms and location of infections. The most frequently observed microorganism was Staphylococcus aureus (in 6 patients). A causative microorganism was not identified in 2 patients. One patient had low-grade fever and showed a mass in the right upper lung field on a plain chest film, which disappeared after the start of therapy with isoniazid and rifampin, suggesting mycobacterial infection. Another had fever, pro- 
Clinical prediction model
Whenthe above variables were entered into a step-wise logistic regression analysis , the independent correlates of infection were, as shown in Table 4 , a decrease in serum albumin value, an increase in serum creatinine value, and prednisolone use at a dose of >60 mg/day without MPPT.The median serum albumin and creatinine values just before infection were 3.0 g/ dl (range, 1. 1-3.7) and 1.0 mg/dl (range, 0.0-3.4), respectively. Although the serum albumin value just before infection was significantly higher than that before corticosteroid therapy (p = 0.0 1 3 by Wilcoxon matched-pairs signed-ranks test), it was still lower than the normal range. The serum creatinine value did not Table 3 change significantly (p = 0.532). The median prednisolone dose just before infection was 40 mg/day (range: 30-80 mg/dl).
As shown in Fig. 1 , the ROCcurves were constructed using the bootstrap and cross-validation estimates of Se and Sp as well as apparent Se and Sp. The bootstrap method and crossvalidation showed almost the same results in the performance of the prediction model. In order to minimize mistakes we selected a cutoff point to predict future infection from the estimated probability 0.05-0.95. The smallest error rate was obtained when the cutoff point was 0.35 and 0.50 for the training sample. It is known that the optimal cutoff point on the ROC curve occurs where the slope of the ROCcurve equals
where P(D+) and P(D-) denote the prior or pretest probability of infection and that of no infection respectively, and ACfp and ACfn denote the additional health cost associated with a falsepositive error and with a false-negative error in prediction respectively (26). Although we did not know accurate estimates of the additional health costs, ACfn was presumed to be much higher than ACfp. This is because the nonsurvivors were all included in the infectious group. The low ACfp/ACfn ratio suggested that it might be desirable to use the smallest predicted value in the range described above as a cutoff point. Therefore we selected an estimated probability of 0.35 as a cutoff point, which made an apparent error, Se, and Sp of 10%, 71%, and 93% in the training sample, respectively, 12%, 65%, and 91% in cross-validation, and 12%, 61%, and 92% in the bootstrap method. The positive predictive value (PPV) and odds ratio were 55%and 6.2 in cross-validation.
Using this cutoff point, all nonsurvivors were correctly predicted. Whenthe ROC curves for cross-validation and the prediction using the SLEDAI were compared (Fig. 1) , the area under the curve in the former was slightly larger than that in the latter (0.846 vs 0.727, p = 0.056). For the SLEDAI, the error rate was lowest whenthe SLEDAIwas >34. However, the error, Se, and Sp were the 14%, 0%, and 99%, making prediction impractical. When a SLEDAIscore of 16 was used as the cutoff point, Se of65%, as obtained in our prediction model described above, was accompanied by Sp of71 %, error of30%, PPV of27%, and odds ratio of 3.6. These results suggest a slightly poorer performance of the SLEDAI. Figure 1 . ROCcurves for the prediction of infection in the training sample using the model developed in the present study (indicated by "apparent") and using the SLEDAI score. ROC curves were also obtained using sensitivity and specificity estimated by 10-fold cross-validation and the bootstrap method. SLEDAI: SLE Disease Activity Index (20) .
Discussion
Wehave identified independent clinical predictors for infection in hospitalized patients with active SLEand used them to derive and validate a clinical prediction model that allows discrimination of patients according to their risk for infection. The independent predictors of infection, all of which were available at the time of admission, were a decrease in serum albuminvalue, an increase in serum creatinine value, and prednisolone use in a dose of^60 mg/day without MPPT. Predicted values of infection, calculated using the logistic regression model with the coefficients shown in useful when a predicted value of0.35 was selected as the cutoff point.
To our knowledge, there has been only one study evaluating risk factors for infection in SLE using multivariate analysis.
From the results of a logistic regression analysis using the SLEDAI score, duration of disease and prednisone dose at the time of admission as independent variables, Duffy et al (27) concluded that the SLEDAI contributed significantly to prediction of infection. They selected a SLEDAI score of 8 as a cutoff point so that the odds ratio reached the maximum2.7, and the Se, Sp, errorrate, andPPV were 60.5%, 63.9%, 37%, and46%, respectively. As noted above in "Results", the performance of the prediction model using only the SLEDAIscore was poor for practical use, although an increase in overall disease activity of SLEmay be a risk factor for infection. It may be that the SLEDAI was not selected by logistic regression analysis in our study because preventative means against infection were taken in patients with high activity of SLE. But even when all patients of prophylactic use of antibiotics were presumed to contract infection, the SLEDAI was not selected. It is possible that our estimate of anti-DNA antibody in patients with missing data affected the performance of the model. But even when all patients with missing data and infection were presumed to have positive anti-DNA antibody and patients with missing data and no infection were presumed to have negative anti-DNA antibody, SLEDAIwas not selected. In the study ofDuffy et al (27), corticosteroid dosage did not contribute significantly to the prediction model. This is perhaps because they used a corticosteroid dose only at the time of admission, and not at the start of therapy, as an independent variable. In addition, there is a difference in the mean±SDof SLEDAIscore (7.9±1.2 in their study vs 13.1±6.7 in ours) and in the frequency of infection (0.333 vs 0.140) between their study and ours, suggesting a difference in clinical characteristics of the study populations.
There have been no previous reports documenting the utility of the serumalbumin value as an independent risk factor for infection in patients with SLE. Lupus nephritis, which may result in nephrotic syndrome or renal failure, is presumed to be the major cause of hypoalbuminemia seen in SLE patients.
Depressed immunity and a high prevalence of infection have been reported in patients with nephrotic syndromeor renal failure resulting from a variety of renal disorders (28, 29). In addition, hypoalbuminemia has been reported in a wide variety of clinical settings to be an indicator of a poor outcome, including complicating infection (18, (30) (31) (32) . However, supplemental administration of albumin offers no apparent advantage (33, 34), suggesting that albumin itself does not play a key role in the defense mechanism. In critically ill patients, hypoalbuminemiais commonand is considered to be a result of decreased albumin synthesis (35), redistribution of protein from the intravascular to the extravascular space (36), increased albumin breakdown (37), and dilution (38). Malnutrition accompanied by hypoalbuminemia is also associated with decreased humoral and cell-mediated immunity (39). In patients with SLE, hypoalbuminemia appears to result from a variety of factors, and reflects the overall severity of SLE in a given patient rather than disease activity at any one time. This possibility is also supported by the fact that the development of infection was associated more significantly with a decrease in serum albumin value than with an increase in the urinary protein level or the presence of active urinary sediment. Sixty-five percent Se of our prediction model may seem too low for practical use. But our model predicted infection correctly in all nonsurvivors and therefore may be useful for identifying patients with unfavorable prognosis. This is clinically significant. It maybe desirable to take the presence or absence of risk of infection into consideration as a confounding factor when one investigates and reports the prognosis of SLE or the results of a clinical study of therapy in SLE patients.
To what degree does numerical probability such as PPV contribute to physicians ' determinations of diagnosis or treatment? It has been demonstrated that physicians ' intuitive judgment of the likelihood of a variety of medical outcomes may be unreliable (45), and that physicians ' subjective estimates of the prior probability of disease are inaccurate (46). This is probably because cognitive biases and inappropriate use of heuristics may affect physicians' judgment (45). Physicians frequently use verbal probability terms such as "rare", "sometimes,"
"often," and "usually" instead of numerical probability. But for inexperienced physicians and those outside their ownspecialities, the ambiguity of terms of verbal probability impacts their decision-making (47). Therefore the use of numerical probabilities is to be preferred not only for decision-making, but also in teaching materials and in communication between physicians.
Our results must be interpreted with respect to several limitations inherent in the study. The investigation was done at a tertiary care institution, and the result may not be generalizable to other types of hospitals or clinical settings. Also, relationships between infection and clinical predictors may not be generalizable to all patients with active SLE, because all data were from patients whomphysicians felt needed admission, although the numberof patients whowere not admitted in spite of active disease is assumed to be small. The prediction model developed using all SLE patients, including outpatients, which was followed at the same center and is outside the scope of the present study, may be more useful. But we face several problems in such model-building. A major problem is the selection of time of prediction and time of infection to be predicted. For example, data at the first visit or after a certain disease duration maybe available. But such data can be expected to be useful example, a sample were taken whenSLEis inactive and an increase in disease activity that occurred before the next sampling was followed by infection, the infectious risk associated with disease activity would be underestimated. Although the use of a central venous catheter and cytotoxic agents have been reported to correlate with infection (9, 48), they were not selected by logistic regression analysis in our study. This is probably because the number of patients using these catheters or taking these agents wastoo small. In addition to the variables used in the present study, urinary catheterization, parenteral nutrition, mechanical ventilation, tracheostomy, and hemodialysis are all known to significantly increase the risk of hospital-acquired infections (49, 50) and may increase the mortality rate; we could not, however,evaluate these factors in this study because the number of patients having these procedures was also too small. Some clinical findings that correlate with infection mayoccur too rarely to have been identified as risk factors, yet may be powerful predictors.
In conclusion, we have developed a model for the prediction of infection in hospitalized patients with active SLE. This model will give physicians a rational basis for estimating risk for infection in such patients, and may be helpful in deciding whetherto start empiric antibiotic therapy, especially when patients have clinical findings suggestive of infection. Wehope to see the development of a model to predict infection throughout the course of SLEusing appropriate statistical methods in the future.
